Cerus Corporation is a biomedical products company that develops and sells the INTERCEPT Blood System to enhance blood safety. The system is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers systems for platelets, plasma, red blood cells, and cryoprecipitation. It sells its products through direct sales and distributors in various regions. The company was founded in 1991 and is headquartered in Concord, California.